CoChat

Acetyl‐ l ‐carnitine vs tamoxifen in the oral therapy of Peyronie's disease: a preliminary report

Biagiotti, G., Cavallini, G. · 2001 · BJU International
Cited by 142

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Objective To detect whether oral acetyl‐ l ‐carnitine might be useful in the acute and early chronic phases of Peyronie's disease, compared with tamoxifen, a drug currently in use. Patients and methods The study included 48 patients with Peyronie's disease (15 acute and 33 initial chronic), randomized equally into two groups. The first group used tamoxifen 20 mg twice daily for 3 months and the second acetyl‐ l ‐carnitine 1 g twice daily for 3 months. The disease and stages were diagnosed and identified using a history, objective examination, pharmacologically induced erection, autophotography during erection, and basic and dynamic colour Doppler ultrasonography. Penile curvature, plaque size, pain and disease progression were assessed. The differences between the groups or between the variables before and after therapy were compared using analysis of variance or the chi‐squared test. Results Acetyl‐ l ‐carnitine was significantly more effective than tamoxifen in reducing pain and in inhibiting disease progression. Acetyl‐ l ‐carnitine reduced penile curvature significantly, while tamoxifen did not; both drugs significantly reduced plaque size. Tamoxifen induced significantly more side‐effects than acetyl‐ l ‐carnitine. Conclusions These results suggest that acetyl‐ l ‐carnitine is significantly more effective and safe than tamoxifen in the therapy of acute and early chronic Peyronie's disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1464-410x.2001.02241.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 142

Metadata

Authors
Biagiotti, G., & Cavallini, G.
Venue
BJU International
Publisher
Wiley
Published
2001-07
Volume
88
Issue
1
Pages
63-67
ISSN
  • 1464-4096 (ISSN-L)
  • 1464-410X
OpenAlex
W1927590389
Cited by
142
References
1
FWCI
1.01
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Acetyl‐ l ‐carnitine vs tamoxifen in the oral therapy of Peyronie's disease: a preliminary report. https://app.cochat.ai/papers/10.1046/j.1464-410x.2001.02241.x
The paper
Biagiotti, G., & Cavallini, G. (2001). Acetyl‐ l ‐carnitine vs tamoxifen in the oral therapy of Peyronie's disease: a preliminary report. BJU International. https://doi.org/10.1046/j.1464-410x.2001.02241.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.